Beam Therapeutics Stock Price History
| BEAM Stock | USD 19.58 1.59 7.51% |
Below is the normalized historical share price chart for Beam Therapeutics extending back to February 06, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beam Therapeutics stands at 19.58, as last reported on the 16th of July 2025, with the highest price reaching 21.69 and the lowest price hitting 19.40 during the day.
If you're considering investing in Beam Stock, it is important to understand the factors that can impact its price. Beam Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Beam Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0759, which signifies that the company had a 0.0759 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Beam Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Beam Therapeutics' risk adjusted performance of 0.0902, and Mean Deviation of 3.19 to double-check if our risk estimates are consistent with your expectations. At this time, Beam Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 16th of July 2025, Sale Purchase Of Stock is likely to grow to about 915.6 M, while Total Stockholder Equity is likely to drop about 515.8 M. . At this time, Beam Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 16th of July 2025, Price To Book Ratio is likely to grow to 2.92, while Price Earnings Ratio is likely to drop (5.69). Beam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of February 2020 | 200 Day MA 22.9573 | 50 Day MA 17.8791 | Beta 2.083 |
Sharpe Ratio = 0.0759
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BEAM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.4 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average Beam Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beam Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.8954 | Enterprise Value Ebitda (7.03) | Price Sales 30.9684 | Shares Float 86.3 M | Wall Street Target Price 44.0667 |
Beam Therapeutics Stock Price History Chart
There are several ways to analyze Beam Stock price data. The simplest method is using a basic Beam candlestick price chart, which shows Beam Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 10, 2025 | 22.03 |
| Lowest Price | May 30, 2025 | 15.83 |
Beam Therapeutics July 16, 2025 Stock Price Synopsis
Various analyses of Beam Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Beam Stock. It can be used to describe the percentage change in the price of Beam Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Beam Stock.| Beam Therapeutics Price Rate Of Daily Change | 0.92 | |
| Beam Therapeutics Price Action Indicator | (1.76) | |
| Beam Therapeutics Price Daily Balance Of Power | (0.69) | |
| Beam Therapeutics Accumulation Distribution | 317,624 |
Beam Therapeutics July 16, 2025 Stock Price Analysis
Beam Stock Price History Data
The price series of Beam Therapeutics for the period between Thu, Apr 17, 2025 and Wed, Jul 16, 2025 has a statistical range of 7.4 with a coefficient of variation of 8.91. The prices are distributed with arithmetic mean of 17.94. The median price for the last 90 days is 17.28. The company had 2:1 stock split on October 26, 1990. Beam Therapeutics issued dividends on Feb 4, 2014.| Open | High | Low | Close | Volume | ||
07/15/2025 | 21.34 | 21.69 | 19.40 | 19.58 | 3,008,411 | |
| 07/14/2025 | 21.12 | 21.75 | 20.75 | 21.17 | 2,001,473 | |
07/11/2025 | 21.73 | 22.19 | 20.95 | 21.16 | 2,297,742 | |
07/10/2025 | 22.51 | 22.51 | 21.04 | 22.03 | 3,305,060 | |
| 07/09/2025 | 21.76 | 22.39 | 20.86 | 21.46 | 3,958,377 | |
07/08/2025 | 19.37 | 20.71 | 19.28 | 20.30 | 3,073,377 | |
07/07/2025 | 19.92 | 20.05 | 19.02 | 19.18 | 2,770,285 | |
| 07/03/2025 | 20.20 | 20.46 | 19.57 | 20.01 | 1,364,708 | |
| 07/02/2025 | 17.66 | 20.15 | 17.66 | 19.88 | 4,002,155 | |
07/01/2025 | 16.85 | 18.23 | 16.59 | 17.53 | 1,583,674 | |
06/30/2025 | 17.00 | 17.73 | 16.86 | 17.01 | 1,531,677 | |
06/27/2025 | 17.32 | 17.51 | 16.75 | 16.80 | 4,494,440 | |
06/26/2025 | 16.80 | 17.23 | 16.49 | 17.14 | 1,295,202 | |
06/25/2025 | 17.16 | 17.33 | 16.63 | 16.76 | 1,497,126 | |
06/24/2025 | 17.15 | 17.38 | 16.83 | 17.15 | 1,314,673 | |
| 06/23/2025 | 16.67 | 16.93 | 16.11 | 16.71 | 1,343,868 | |
06/20/2025 | 17.16 | 17.30 | 16.35 | 16.76 | 2,187,756 | |
06/18/2025 | 16.61 | 17.53 | 16.18 | 16.99 | 1,836,856 | |
| 06/17/2025 | 17.47 | 18.33 | 16.54 | 16.67 | 3,324,085 | |
06/16/2025 | 17.55 | 17.55 | 16.38 | 16.62 | 1,632,937 | |
| 06/13/2025 | 16.90 | 17.39 | 16.70 | 17.06 | 1,423,899 | |
06/12/2025 | 17.56 | 17.74 | 17.00 | 17.44 | 1,401,370 | |
06/11/2025 | 18.40 | 18.45 | 17.75 | 17.89 | 1,768,705 | |
06/10/2025 | 18.27 | 19.05 | 18.07 | 18.08 | 1,263,100 | |
06/09/2025 | 19.45 | 19.45 | 17.92 | 18.17 | 1,568,505 | |
| 06/06/2025 | 17.63 | 18.97 | 17.33 | 18.58 | 3,902,820 | |
| 06/05/2025 | 17.13 | 17.63 | 16.70 | 17.00 | 2,030,281 | |
06/04/2025 | 16.89 | 17.49 | 16.84 | 17.15 | 1,352,912 | |
06/03/2025 | 16.52 | 16.95 | 15.80 | 16.88 | 1,479,971 | |
06/02/2025 | 16.00 | 16.82 | 15.68 | 16.19 | 1,993,753 | |
05/30/2025 | 16.15 | 16.39 | 15.35 | 15.83 | 2,293,796 | |
| 05/29/2025 | 16.79 | 16.79 | 15.36 | 16.32 | 2,327,088 | |
05/28/2025 | 17.06 | 17.27 | 16.73 | 16.88 | 1,402,606 | |
05/27/2025 | 17.30 | 17.47 | 16.92 | 17.03 | 1,333,843 | |
05/23/2025 | 16.70 | 17.11 | 16.61 | 16.83 | 962,009 | |
05/22/2025 | 17.14 | 17.48 | 16.71 | 17.24 | 1,332,536 | |
05/21/2025 | 17.42 | 17.78 | 16.93 | 17.22 | 1,857,047 | |
05/20/2025 | 17.62 | 18.31 | 17.26 | 17.75 | 1,434,949 | |
05/19/2025 | 17.48 | 18.00 | 17.21 | 17.66 | 1,071,603 | |
05/16/2025 | 17.48 | 17.96 | 17.18 | 17.89 | 1,654,170 | |
05/15/2025 | 17.20 | 17.32 | 16.65 | 17.25 | 1,207,027 | |
05/14/2025 | 18.00 | 18.42 | 16.87 | 17.24 | 1,662,788 | |
05/13/2025 | 18.50 | 18.75 | 17.78 | 18.05 | 1,731,845 | |
| 05/12/2025 | 18.43 | 19.15 | 17.84 | 18.24 | 2,233,454 | |
05/09/2025 | 17.40 | 18.75 | 17.37 | 17.41 | 2,383,498 | |
05/08/2025 | 16.26 | 17.75 | 15.64 | 17.25 | 3,148,638 | |
05/07/2025 | 16.20 | 16.24 | 15.51 | 16.23 | 2,638,274 | |
05/06/2025 | 19.30 | 19.34 | 15.65 | 15.99 | 5,154,814 | |
05/05/2025 | 19.86 | 20.05 | 19.30 | 19.82 | 1,957,569 | |
05/02/2025 | 20.04 | 20.90 | 19.94 | 20.24 | 1,778,081 | |
05/01/2025 | 19.94 | 20.58 | 19.31 | 19.83 | 1,605,222 | |
04/30/2025 | 19.13 | 20.08 | 18.91 | 19.93 | 2,085,092 | |
04/29/2025 | 19.80 | 20.20 | 19.28 | 19.71 | 1,535,488 | |
04/28/2025 | 19.59 | 20.17 | 19.36 | 19.80 | 1,269,898 | |
04/25/2025 | 19.81 | 19.97 | 19.39 | 19.52 | 1,222,414 | |
04/24/2025 | 19.87 | 20.20 | 19.45 | 20.17 | 1,719,568 | |
04/23/2025 | 20.00 | 20.81 | 19.85 | 19.87 | 2,132,760 | |
04/22/2025 | 18.38 | 19.31 | 18.34 | 19.13 | 1,977,604 | |
04/21/2025 | 16.78 | 19.48 | 16.66 | 18.24 | 3,277,571 | |
04/17/2025 | 16.58 | 17.20 | 16.49 | 17.00 | 1,136,488 | |
04/16/2025 | 16.98 | 16.98 | 16.04 | 16.62 | 1,737,685 |
About Beam Therapeutics Stock history
Beam Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Beam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Beam Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Beam Therapeutics stock prices may prove useful in developing a viable investing in Beam Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 82.3 M | 60.5 M | |
| Net Loss | -234.2 M | -245.9 M |
Beam Therapeutics Quarterly Net Working Capital |
|
Beam Therapeutics Stock Technical Analysis
Beam Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Beam Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Beam Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Beam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Beam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0902 | |||
| Jensen Alpha | 0.1351 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | 0.0508 | |||
| Treynor Ratio | 0.1846 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.61) | Revenue Per Share | Quarterly Revenue Growth 0.008 | Return On Assets | Return On Equity |
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.